1.888.321.7828 sales@pepid.com

Timely Insights for Healthcare Experts 

When Seconds Count: The Benefits of Drug Data Alerts

When Seconds Count: The Benefits of Drug Data Alerts

Drug overdoses have become a significant public health crisis, with devastating consequences for individuals, families, and communities. Alarming data from the World Health Organization (WHO) underscore the gravity of the situation, indicating that drug overdoses are...

read more
Insulin’s Rising Costs: A Barrier to Diabetes Care

Insulin’s Rising Costs: A Barrier to Diabetes Care

 The price of insulin in the United States has risen more than 1000% over the past 20 years. Many reports and data over recent years have revealed that human insulin has often been inaccessible to certain demographics due to its high cost. Unfortunately, this has...

read more
Omicron Variant – Preliminary Findings

Omicron Variant – Preliminary Findings

VOC: Omicron The World Health Organization officially stamped the Omicron SARS-CoV-2 variant as a variant of concern (VOC) on November 26. Omicron was first identified in South Africa and has been detected in more than twenty-eight countries worldwide, including the...

read more
Peripheral Nerve Blocks for Headaches in the ED

Peripheral Nerve Blocks for Headaches in the ED

Headaches are common in the ED department, making up for approximately 2% of ED visits. Primary Headache Disorder includes migraine, tension headaches, and trigeminal autonomic cephalgias (TACS). That’s up to 1.2 million patients walking in the Emergency Department to...

read more
The Emergence of the Delta Variant

The Emergence of the Delta Variant

Sena Seged, Pharm D August 27, 2021Overview of Coronaviruses Coronaviruses are not new to us – they are a family of RNA or protein-based viruses that rarely infect humans. Coronaviruses are responsible for causing common colds and lower respiratory tract infections....

read more
The Latest Variant of Interest: Lambda C.37

The Latest Variant of Interest: Lambda C.37

The Lambda Variant The Lambda variant of SARS-CoV-2 currently spreading through South America has been classified as a Variant of Interest by the World Health Organization on June 14, 2021. The Lambda C.37 variant was first reported in Peru in December 2020 and has...

read more
The Delta Variant & U.S. COVID-19 Vaccine Updates

The Delta Variant & U.S. COVID-19 Vaccine Updates

Delta Variant Dominant in U.S. As of July 19, 2021, the Delta variant represents 57.6% of total U.S. COVID-19 cases. In some parts of the country, this percent is higher, especially in areas with low vaccination rates. Since the Delta variant was first detected in the...

read more
CVST with Thrombocytopenia following J&J COVID-19 Vaccine

CVST with Thrombocytopenia following J&J COVID-19 Vaccine

April 23, 2021 Update The Advisory Committee on Immunization Practices (ACIP) concluded the benefits of resuming the Janssen COVID-19 vaccine for people 18 and older outweighed the risks. In the advisory meeting 10 participants voted yes, 4 voted no, and 1 abstained....

read more
Tools that Improve Patient Safety

Tools that Improve Patient Safety

During Patient Safety Awareness Week, we're highlighting fast and easy-to-use tools that improve patient safety at the point-of-care to avoid ADRs, improve patient education, & verify clinical conditions.March 14-20 is Patient Safety Awareness Week. Patient Safety...

read more